Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Regulating regulatory T cells to achieve transplant tolerance Tao R; Hancock WWHepatobiliary Pancreat Dis Int 2007[Aug]; 6 (4): 348-57BACKGROUND: Regulatory T cells (Tregs) play crucial roles in both induction and maintenance of tolerance. This active immune regulation may contribute not only to the control of immune responses to self-antigens and thereby prevent autoimmune diseases, but also the control of responses to non-self molecules in adaptive immunity. Numerous experimental and clinical studies indicate that manipulating the balance between regulatory and responder T cells is an effective strategy to control immune responsiveness after transplantation. DATA SOURCES: Literature search was conducted using PubMed on the related subjects. Part of the material was based on the most recent work in the authors' laboratory. RESULTS: We propose some new strategies to achieve transplant tolerance in rodent animals via manipulating Treg function, including using histone deacetylase (HDAC) inhibitor to regulate Foxp3 transcription and enhance Treg suppression, induction of Treg-sparing apoptosis via Nur77, and identification of the co-inhibitory molecule herpes virus entry mediator (HVEM) as an effector molecule for Treg function. CONCLUSION: Regulation of Treg function will definitely provide us very promising tools to achieve clinical tolerance in the future.|*Transplantation Tolerance[MESH]|Animals[MESH]|Apoptosis[MESH]|Autoantigens[MESH]|Autoimmune Diseases/*prevention & control[MESH]|DNA-Binding Proteins/physiology[MESH]|Enzyme Inhibitors/pharmacology[MESH]|Forkhead Transcription Factors/metabolism[MESH]|Histocompatibility Testing/methods[MESH]|Histone Deacetylase Inhibitors[MESH]|Humans[MESH]|Ligands[MESH]|Liver Transplantation/*methods[MESH]|Nuclear Receptor Subfamily 4, Group A, Member 1[MESH]|Receptors, Cytoplasmic and Nuclear/physiology[MESH]|Receptors, Steroid/physiology[MESH]|T-Lymphocytes, Regulatory/*cytology[MESH]|Transcription Factors/physiology[MESH]|Treatment Outcome[MESH] |